Comparative efficacy of long-acting muscarinic antagonist monotherapies in COPD: a systematic review and network meta-analysis

BACKGROUND: Randomized, controlled trials comparing long-acting muscarinic antagonist (LAMA) efficacy in COPD are limited. This network meta-analysis (NMA) assessed the relative efficacy of tiotropium 18 µg once-daily (OD) and newer agents (aclidinium 400 µg twice-daily, glycopyrronium 50 µg OD, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismaila, Afisi Segun, Huisman, Eline L, Punekar, Yogesh Suresh, Karabis, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655912/
https://www.ncbi.nlm.nih.gov/pubmed/26604738
http://dx.doi.org/10.2147/COPD.S92412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655912/
https://www.ncbi.nlm.nih.gov/pubmed/26604738
http://dx.doi.org/10.2147/COPD.S92412

Ejemplares similares